← Eichor
Study identifier: NCT04033497 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

Condition: Brain Tumor  ·  Sponsor: Brigham and Women's Hospital

PhaseNA
Planned participants101
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This research study is investigating the value of an imaging study of the brain called an MRI (which stands for magnetic resonance imaging), utilized in unique way, to delineate whether the tumor has recurred or whether radiation changes have occurred after a brain metastasis treated with focused radiation has enlarged.

This description comes directly from the study's public registry record.

Talk to the study team

Ayal Aizer, MD, MHS  ·  617-732-7560  ·  aaaizer@partners.org

Ivy Ricca, BA  ·  6175828927  ·  iricca@mgb.org

Always discuss trial participation with your own doctor first.

Locations (2)

Brigham and Women's HospitalBoston, Massachusetts, United StatesRecruiting
Dana Farber Cancer InstituteBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04033497